Papillary thyroid cancer laboratory findings: Difference between revisions
(Created page with "__NOTOC__ {{Papillary thyroid cancer}} {{CMG}}; {{AE}} {{Ammu}} ==Overview== ==Laboratory Findings== Thyroglobulin can be used as a tumor marker for well-Cellular d...") |
No edit summary |
||
| Line 9: | Line 9: | ||
Reduced expression of [[ATP5E]] is significantly associated with the diagnosis of papillary thyroid cancer and may serve as an early tumor marker of the disease.<ref>{{cite journal|last1=Hurtado-López|first1=LM|last2=Fernández-Ramírez|first2=F|last3=Martínez-Peñafiel|first3=E|last4=Carrillo Ruiz|first4=JD|last5=Herrera González|first5=NE|title=Molecular Analysis by Gene Expression of Mitochondrial ATPase Subunits in Papillary Thyroid Cancer: Is ATP5E Transcript a Possible Early Tumor Marker?|journal=Medical science monitor : international medical journal of experimental and clinical research|date=16 June 2015|volume=21|pages=1745-51|pmid=26079849}}</ref> | Reduced expression of [[ATP5E]] is significantly associated with the diagnosis of papillary thyroid cancer and may serve as an early tumor marker of the disease.<ref>{{cite journal|last1=Hurtado-López|first1=LM|last2=Fernández-Ramírez|first2=F|last3=Martínez-Peñafiel|first3=E|last4=Carrillo Ruiz|first4=JD|last5=Herrera González|first5=NE|title=Molecular Analysis by Gene Expression of Mitochondrial ATPase Subunits in Papillary Thyroid Cancer: Is ATP5E Transcript a Possible Early Tumor Marker?|journal=Medical science monitor : international medical journal of experimental and clinical research|date=16 June 2015|volume=21|pages=1745-51|pmid=26079849}}</ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | |||
[[Category:Help]] | [[Category:Help]] | ||
[[Category:Templates]] | [[Category:Templates]] | ||
Revision as of 14:27, 3 November 2015
|
Papillary thyroid cancer Microchapters |
|
Differentiating Papillary thyroid cancer from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Papillary thyroid cancer laboratory findings On the Web |
|
American Roentgen Ray Society Images of Papillary thyroid cancer laboratory findings |
|
Risk calculators and risk factors for Papillary thyroid cancer laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Laboratory Findings
Thyroglobulin can be used as a tumor marker for well-differentiated papillary thyroid cancer.[1][2] HBME-1 staining may be useful for differentiating papillary carcinomas from follicular carcinomas; in papillary lesions it tends to be positive.[3]
Reduced expression of ATP5E is significantly associated with the diagnosis of papillary thyroid cancer and may serve as an early tumor marker of the disease.[4]
References
- ↑ Lin JD (2007). "Thyroglobulin and human thyroid cancer". Clin Chim Acta. 388 (1–2): 15–21. doi:10.1016/j.cca.2007.11.002. PMID 18060877.
- ↑ Tuttle RM, Leboeuf R, Martorella AJ (2007). "Papillary thyroid cancer: monitoring and therapy". Endocrinol. Metab. Clin. North Am. 36 (3): 753–78, vii. doi:10.1016/j.ecl.2007.04.004. PMID 17673127.
- ↑ Papotti M, Rodriguez J, De Pompa R, Bartolazzi A, Rosai J (April 2005). "Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential". Mod. Pathol. 18 (4): 541–46. doi:10.1038/modpathol.3800321. PMID 15529186.
- ↑ Hurtado-López, LM; Fernández-Ramírez, F; Martínez-Peñafiel, E; Carrillo Ruiz, JD; Herrera González, NE (16 June 2015). "Molecular Analysis by Gene Expression of Mitochondrial ATPase Subunits in Papillary Thyroid Cancer: Is ATP5E Transcript a Possible Early Tumor Marker?". Medical science monitor : international medical journal of experimental and clinical research. 21: 1745–51. PMID 26079849.